Bridgepoint Snags Identicare From Animalcare – A Quick Deal That Feels Like a Good Friend’s Move
Bridgepoint – a FTSE 250 private‑equity juggernaut – has just taken a majority stake in Identicare Ltd, the UK’s oldest pet‑microchip database and pet‑protection service. The transaction gives Animalcare Group plc the cash, breathing room, and bigger‑picture focus they need to grow their slick pharmaceutical‑based animal‑health book.
What Identicare Brings to the Table
- Handles the full pet microchip & registration lifecycle.
- Owns a single, integrated database that’s been around since the old days.
- Offers “lost‑pet” protection – pets that go missing or stolen are tracked and recovered.
- Founded in March 2021 after a split from Animalcare’s UK pharma arm.
Why This Deal Matters for Animalcare
Animalcare’s CEO, Jenny Winter, explains the move plainly: “It’s a logical next step that makes our balance sheet rock-solid. We’ll have the firepower to double‑down on the pharmaceutical side of the business.” The cash infusion also lets them press on with both organic growth and the occasional acquisition.
On the other side, Identicare CEO Robert Diamond is staying on to lead the company into this exciting new chapter with Bridgepoint—so the team chemistry stays intact.
FRP Corporate Finance: The Deal Whisperers
London’s own FRP Corporate Finance, led by Mark Farlow, Ed Shurville‑Darlington, and Olivia Norris, headed the sale from start to finish. They were responsible for:
- Preparing the deal – laying out the paper trail and value.
- Negotiating the terms – ensuring a smooth “sell‑off” for the shareholders.
- Managing due diligence – keeping every aspect of the package cleaner than a freshly polished lab coat.
- Closing the transaction – sealing the deal with the efficiency of a seasoned banker.
Matching Market Momentum
Mark Farlow, the FRP partner, points out the big picture: “You can see the pet‑ownership boom that exploded during the pandemic. That’s a sturdy market, attracting lots of investors.” This upward trend makes Identicare an enticing acquisition target for a firm like Bridgepoint.
Reinforcing Animalcare’s Future
Jenny Winter was enthusiastic too: “We’ve grown Identicare dramatically, and now we’re ready to lean into the pharma side. With the FRP team’s help, we weighed multiple options, pulled the best one, and created significant value for our shareholders.”
Takeaway
In a nutshell, Identicare’s sale to Bridgepoint is a masterstroke for Animalcare: it unlocks capital, strategically resets the company’s priorities, and keeps the pet‑data platform under passionate leadership to scale further.
